𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia

✍ Scribed by Paul J Limburg; Mary E Devens; Jonathan J Harrington; Nancy N Diehl; Douglas W Mahoney; David A Ahlquist

Book ID
119394239
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
98 KB
Volume
98
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prospective multicenter evaluation of fe
Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia
✍ Yogesh M. Shastri; Marc Naumann; Gerhard M. Oremek; Ernst Hanisch; Wolfgang RΓΆsc πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 136 KB

## Abstract Proliferating cells, particularly the tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed M2‐PK. It's a direct target of several oncoproteins; the determination of fecal tumor pyruvate kinase type M2 (M2‐PK) might be another promising tool for colorectal cancer (CRC) scr

Evaluation of an automated immunochemica
Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population
✍ Wai Man Wong; Shiu Kum Lam; Kwan Lok Cheung; Teresa Sze Man Tong; Paul Rozen; Gr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Most commercial fecal occult blood tests (FOBT) used for colorectal carcinoma screening of Western populations are guaiac‐based, manually developed, subjective, and sensitive to dietary components. Preliminary studies demonstrated the unsuitability of these tests for scre